DIRS.INFO The most relevant business & tech news

☆ Neurable’s BCI ‘brain-reading’ headphones could stop you burning out
▼ + stars: | 2024-09-17 | by ( Rebecca Cairns | ) edition.cnn.com time to read: +9 min

The MW75 Neuro comes in four colors, including silver. NeurableThe concept, says Alcaide, is to help users “build discipline and good habits” through rewarding good cognitive hygiene. Blackrock NeurotechThe MW75 Neuro is a "non-invasive" BCI. CNN’s Anna Stewart tries an early iteration of Neurable’s MW75 Neuro headphones with Deena Al Jassasi (right) at Healthspan Digital, a longevity clinic in Dubai. As more people wear the headphones, Alcaide says users can opt-in to share their anonymized data which can help improve functionality for new software features.

Persons: Ramses Alcaide, Woojin Lee, Neurable, Alcaide, you’re, ”, Miguel Nicolelis, Adam Molnar, ” Miguel Nicolelis, Neurobiologist, Duke University Nicolelis, Deena Al Jassasi, CNN’s Anna Stewart Organizations: CNN, University of Michigan’s, Interface, Dynamics, Duke University, Neurable, BCI, Blackrock, DCI Network, Institute of Neuroethics, Healthspan Locations: Boston, Alcaide, Blackrock Neurotech's Utah, Dubai

☆ FDA rejection of MDMA-assisted therapy rattles advocates but doesn’t spell end of psychedelics in medicine, experts say
▼ + stars: | 2024-08-13 | by ( Deidre Mcphillips | Carma Hassan | ) edition.cnn.com time to read: +11 min

The initial application from Lykos presented positive data from two late-stage clinical trials that used MDMA in combination with talk therapy to treat PTSD. The advisers said it was also difficult to parse how much the accompanying talk therapy — an area that the FDA does not regulate — contributed to outcomes. Advocates for the treatment, including some veterans groups, said they were “incredibly disappointed” by the FDA decision. Dozens of clinical trials involving psychedelics are in various stages, and additional scrutiny can help strengthen the findings and build confidence. Psychopharmacology did not allow the study authors to publish a correction with data that excluded findings from one study site, said Allison Feduccia, an author in all three retracted studies.

Persons: Lykos, —, ” Martin Steele, Brett Waters, ”, Rachel Yehuda, “, ‘, Michael Bogenschutz, Yehuda, It’s, Lori Bruce, Psychopharmacology, caressed, “ it’s, Amy Emerson, ” Lykos, Allison Feduccia, Dr, Sanjay Gupta, Brian Barnett, ” Bruce, Nadia Kounang Organizations: CNN, Food and Drug Administration, Lykos Therapeutics, FDA, Veteran Mental Health Leadership Coalition, Hope, Center, Psychedelic Psychotherapy, Mount, Icahn, of Medicine, NYU Langone Center, Psychedelic Medicine, Oxford, NUS, Neuroethics, Interdisciplinary Center, Bioethics, Yale University, ”, Multidisciplinary Association for Psychedelic Studies, Health Canada, Institutional, Board, CNN Health, Cleveland Clinic Locations: Canada, “

☆ Brain Chips Like Elon Musk's Neuralink Can Change Your Personality
▼ + stars: | 2023-02-15 | by ( Evan Malmgren | ) www.businessinsider.com time to read: +13 min

Musk's neurotech startup, Neuralink, has been working toward implanting its skull-embedded brain chip in a human since it was founded in 2016. Other researchers have been looking into using BCIs to restore lost senses and control prosthetic limbs, among other applications. Intervening in the delicate operation of a human brain is a sticky business, and the effects are not always desirable or intended. If a brain chip can change key parts of your personality, companies should not be rushing to put them in people's heads. Wexler told me that while most people in the industry aren't that open to using BCIs as a consumer product, they still think it's likely to happen.

Search resuls for: "Neuroethics"

3 mentions found